HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simpson, W. J. Articles by Schwan, T. G. Search for Related Content PubMed PubMed Citation Articles by Simpson, W. J. Articles by Schwan, T. G.

Recombinant Capsular Antigen (Fraction 1) from Yersinia Pestis Induces a Protective Antibody Response in BALB/c Mice

Yersinia pestis produces a glycoprotein capsule, the biosynthesis of which appears to be temperature dependent. The fraction I (F1) component of this capsule is specific to Y. pestis and the detection of F1 antibodies is the basis for several serological tests. We report the cloning of the F1 gene and its expression in Escherichia coli using the phagemid vector ZAPII and a F1-specific monoclonal antibody. The recombinant F1 antigen had a molecular weight of 17 kDa, which proved to be identical to that of the F1 antigen produced by Y. pestis. The recombinant cells produced F1 antigen at 37°C but only minimal amounts at 27°C, suggesting that the genetic features affected by temperature in Y. pestis may be operating in the E. coli clone. It is not known if their similar molecular weights reflect the glycosylated nature of both proteins. F1 antigen purified from the E. coli recombinant induced a protective immune response in BALB/c mice challenged with up to 10⁵ virulent Y. pestis. The resistance of immunized mice to plague infection correlated with high titers of F1 antibody. The cloned gene expresses an immunogenically competent F1 antigen suitable for use in plague serodiagnostics and vaccine development.

This article has been cited by other articles:

				P. A. Arlen, M. Singleton, J. J. Adamovicz, Y. Ding, A. Davoodi-Semiromi, and H. Daniell Effective Plague Vaccination via Oral Delivery of Plant Cells Expressing F1-V Antigens in Chloroplasts Infect. Immun., August 1, 2008; 76(8): 3640 - 3650. [Abstract] [Full Text] [PDF]

				T. Blisnick, P. Ave, M. Huerre, E. Carniel, and C. E. Demeure Oral Vaccination against Bubonic Plague Using a Live Avirulent Yersinia pseudotuberculosis Strain Infect. Immun., August 1, 2008; 76(8): 3808 - 3816. [Abstract] [Full Text] [PDF]

				B. Li and R. Yang Interaction between Yersinia pestis and the Host Immune System Infect. Immun., May 1, 2008; 76(5): 1804 - 1811. [Full Text] [PDF]

				A. P. Anisimov and K. K. Amoako Treatment of plague: promising alternatives to antibiotics. J. Med. Microbiol., November 1, 2006; 55(Pt 11): 1461 - 1475. [Abstract] [Full Text] [PDF]

				J. A. Musson, M. Morton, N. Walker, H. M. Harper, H. V. McNeill, E. D. Williamson, and J. H. Robinson Sequential Proteolytic Processing of the Capsular Caf1 Antigen of Yersinia pestis for Major Histocompatibility Complex Class II-restricted Presentation to T Lymphocytes J. Biol. Chem., September 8, 2006; 281(36): 26129 - 26135. [Abstract] [Full Text] [PDF]

				A. N. Honko, N. Sriranganathan, C. J. Lees, and S. B. Mizel Flagellin Is an Effective Adjuvant for Immunization against Lethal Respiratory Challenge with Yersinia pestis Infect. Immun., February 1, 2006; 74(2): 1113 - 1120. [Abstract] [Full Text] [PDF]